Antioxidant enzymes in renal cell carcinoma

Histology and Histopathology

Volumn 21, Issue 1-3, 2006, Pages 157-165

  Soini, Y ^a   Kallio, J P ^b   Hirvikoski, P ^b   Helin, H ^c   Kellokumpu Lehtinen, P ^b   Tammela, T L J ^b   Peltoniemi, M ^a   Martikainen, P M ^b   Kinnula, V L ^c  

^a UNIVERSITY OF OULU   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cancer; Kidney; Oxidative damage

Indexed keywords

3 NITROTYROSINE; ANTIOXIDANT; EXTRACELLULAR SUPEROXIDE DISMUTASE; GLUTAMATE CYSTEINE LIGASE; MANGANESE SUPEROXIDE DISMUTASE; MONOCLONAL ANTIBODY KI 67; SUPEROXIDE DISMUTASE; THIOREDOXIN; THIOREDOXIN REDUCTASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; DISEASE SEVERITY; FINLAND; FOLLOW UP; HEAVY CHAIN; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LIGHT CHAIN; MAJOR CLINICAL STUDY; NEPHRECTOMY; NICK END LABELING; OXIDATIVE STRESS; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CATALASE; FEMALE; GLUTAMATE-CYSTEINE LIGASE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; SUPEROXIDE DISMUTASE; THIOREDOXIN; THIOREDOXIN REDUCTASE (NADPH); TYROSINE;

EID: 29844444426     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Arner E.S. and Holmgren A. (2000.) Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267, 6102-6109.
2. Bannister A.J., Cook A and Kouzarides T. (1991). In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes. Oncogene 6,1243-1250.
3. Brown D.F., Dababo M.A., Hladik C.L., Eagan K.P., White C.L 3rd. and Rushing E.J. (1998). Hormone receptor immunoreactivity in hemangioblastomas and clear cell renal cell carcinomas. Mod. Pathol. 11, 55-59
4. Chiueh C., Lee S., Andoh T. and Murphy D. (2003). Induction of antioxidative and antiapoptotic thioredoxin supports neuroprotective hypothesis of estrogen. Endocrine 21, 27-31.
5. Dalton T.P., Dieter M.Z., Yang Y., Shertzer H.G. and Nebert D.W. (2000). Knockout of the mouse glutamate cysteine ligase catalytic subunit (Gclc) gene, embryonic lethal when homozygous, and proposed model for moderate glutathione deficiency when heterozygous. Biochem. Biophys. Res. Commun. 279, 324-329.
6. Eble J.N., Sauter G., Epstein J.L. and Sesterhenn I.A. (2004). Tumours of the urinary system and male genital organs. World Health Classification of Tumours. Pathology and genetics. IARC Press, Lyon.
7. Epperly M.W., Bernarding M., Gretton J., Jefferson M., Nie S. and Greenberger J.S. (2003). Overexpression of the transgene for manganese superoxide dismutase (MnSOD) in 32D cl 3 cells prevents apoptosis induction by TNF-alpha, IL-3 withdrawal, and ionizing radiation. Exp. Hematol 31,465-744.
8. Erhola M., Toyokuni S., Okada K., Tanaka T., Hiai H., Ochi H., Uchida K., Osawa T., Nieminen M.M., Alho H.. and Kellokumpu-Lehtinen P. (1997a). Biomarker evidence of DNA oxidation in lung cancer patients, association of urinary 8-hydroxy-2′-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS Lett. 409, 287-291.
9. Erhola M., Nieminen M.M., Kellokumpu-Lehtinen P., Metsa-Ketola T., Poussa T. and Alho H. (1997b). Plasma peroxyl radical trapping capacity in lung cancer patients, a case-control study. Free Radic. Res. 26, 439-447
10. Fano G., Mecocci P., Vacchiet J., Belia S., Fulle S., Polidori M.C., Felzani G., Senin U., Vecchiet L. and Beal M.F. (2001). Age and sex influence on oxidative damage and functional status in human skeletal muscle. J. Muscle Res. Cell. Motil. 22, 345-351.
11. Fridovich I. (1998). Oxygen toxicity, a radical explanation. J. Exp. Biol. 201, 1203-1209.
12. Fridovich I. and Freeman B. (1986). Antioxidant defences in the lung. Annu. Rev. Physiol. 48, 693-702.
13. Grogan T.M., Fenoglio-Prieser C., Zeheb R., Bellamy W., Frutiger Y., Vela E., Stemmerman G., Macdonald J., Richter L., Gallegos A. and Powis G. (2000). Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival. Hum. Pathol. 31, 475-481.
14. Gutteridge J.M. and Halliwell B. (1989). Iron toxicity and oxygen radicals. Baillieres Clin. Hematol. 2, 195-256.
15. Haapasalo H., Kylaniemi M., Paunu N., Kinnula V.L. and Soini Y. (2003). Expression of antioxidant enzymes in astrocytic brain tumors. Brain Pathol. 13, 155-164.
16. Halliwell B. and Gutteridge J. (1996). Free radicals in biology and medicine. Oxford Claredon Press.
17. Hayes J.D. and McLellan L.I. (1999). Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Rad. Res. 31, 273-300.
18. Janssen A.M., Bosman C.B., van Duijn W., Oostendorp-van de Ruit M.M., Kubben F.J., Griffioen G., Lamers C.B., van Krieken J.H., van de Velde C.J. and Verspaget H.W. (2000). Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer. Clin. Cancer Res. 6, 3183-3192.
19. Jarvinen K., Soini Y., Kahlos K. and Kinnula V.L. (2002). Overexpression of gamma-glutamylcysteine synthetase in human malignant mesothelioma. Hum. Pathol. 33, 748-755.
20. Kahlos K., Paakko P., Kurttila E., Soini Y. and Kinnula V.L. (2000). Manganese superoxide dismutase as a diagnostic marker for malignant pleural mesothelioma. Br. J. Cancer 82, 1022-1029.
21. Kahlos K., Soini Y., Paakko P., Saily M., Linnainmaa K. and Kinnula V.L. (2001a). Proliferation, apoptosis, and manganese superoxide dismutase in malignant mesothelioma. Int. J. Cancer 88, 37-43.
22. Kahlos K., Soini Y., Sormunen R., Kaarteenaho-Wiik R., Paakko P., Linnainmaa K. and Kinnula V.L. (2001b). Expression and prognostic significance of catalase in malignant mesothelioma. Cancer 91, 1349-1357.
23. Kallio J.P., Hirvikoski P., Helin H., Kellokumpu-Lehtinen P., Luukkaala T., Tammela T.L. and Martikainen P.M. (2003). Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma. Br. J. Cancer 89, 1266-1269.
24. Kinnula V.L. and Crapo J.D. (2003). Superoxide dismutases in the lung and human lung diseases. Am. J. Respir. Crit. Care Med. 167, 1600-1619.
25. Kinnula V.L. and Crapo J.D. (2004). Superoxide dismutases in malignant cells and human tumors. Free Rad. Biol. Med. 36, 718-744.
26. Li J.J., Oberley L.W., St Clair D.K., Ridnour L.A. and Oberley T.D. (1995). Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase. Oncogene 10, 1989-2000.
27. Luthman M. and Holmgren A. (1982). Rat liver thioredoxin and thioredoxin reductase, purification and characterization. Biochemistry 21,6628-6633.
28. Marklund S.L. (1984). Extracellular superoxide dismutase in human tissues and human cell lines. J. Clin. Invest. 74, 1398-1403.
29. Naglieri E., Lopez M., Lelli G., Morelli F., Amodio A., Di Tonno P., Gebbia N., Di Seri M., Chetri M.C., Rizzo P., Abbate I., Casamassima A., Selvaggi F.P. and Colucci G. (2002). Interleukin-2, interferon-alpha and medroxyprogesterone acetate in metastatic renal cell carcinoma. Anticancer Res. 22,3045-51
30. Nonn L., Williams R.R., Erickson R.P. and Powis G. (2003). The absence of mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and early embryonic lethality in homozygous mice. Mol. Cell. Biol. 23, 916-922.
31. Nozoe T., Honda M., Inutsuka S., Yasuda M. and Korenaga D. (2003). Significance of immunohistochemical expression of manganese superoxide dismutase as a marker of malignant potential in colorectal carcinoma. Oncol. Rep. 10, 39-43.
32. Oberley T.D., Schultz J.L., Li N. and Oberley L.W. (1995a). Antioxidant enzyme levels as a function of growth state in cell culture. Free Radic. Biol. Med. 19, 53-65.
33. Oberley T.D., Sempf J.M. and Oberley L.W. (1995b). Immunohistochemical localization of antioxidant enzymes during hamster kidney development. Histochem. J. 27, 575-586.
34. Ogata M. (1991). Acatalasemia. Hum. Genet. 86, 331-340.
35. Oury T.D., Chang L.Y., Marklund S.L., Day B.J. and Crapo J.D. (1994). Immunocytochemical localization of extracellular superoxide dismutase in human lung. Lab. Invest. 70, 889-898.
36. Powis G. and Montfort W.R. (2001). Properties and biological activities of thioredoxins. Annu. Rev. Pharmacol. Toxicol. 41, 261-295.
37. Radi R., Turrens J.F., Chang L.Y., Bush K.M., Crapo J.D. and Freeman B.A. (1991). Detection of catalase in rat heart mitochondria. Biol. Chem. 266, 22028-22034.
38. Seelig G.F., Simondsen R.P. and Meister A. (1984). Reversible dissociation of gamma-glutamylcysteine synthetase into two subunits. J. Biol. Chem. 259, 9345-9347.
39. Sekura R. and Meister A. (1977). Gamma-glutamylcysteine synthetase. Further purification, "half of the sites" reactivity, subunits and specificity. J. Biol. Chem. 252, 2599-2605
40. Shi T., Dong F., Liou L.S., Duan Z.H., Novick A.C. and DiDonato J.A. (2004). Differential protein profiling in renal cell carcinoma. Mol. Carcinog. 40, 47-61.
41. Slot J.W., Geuze H.J., Freeman B.A. and Crapo J.D. (1986). Intracellular localization of the copper-zinc and manganese superoxide dismutases in rat liver parenchymal cells. Lab. Invest. 55, 363-371.
42. Sobin L.H. and Wittekind C. (2002). International Union Against Cancer. TNM Classification of Malignant tumours. 6th Edition. Wiley-Liss, New York.
43. Soini Y., Virkajärvi N., Lehto V-P. and Pääkkö P. (1996). Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. Br. J. Cancer 73, 1025-1030.
44. Soini Y., Kahlos K., Napankangas U., Kaarteenaho-Wiik R., Saily M., Koistinen P., Paaakko P., Holmgren A. and Kinnula V.L. (2001a). Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma. Clin. Cancer Res. 7,1750-1757.
45. Soini Y., Vakkala M., Kahlos K., Paakko P. and Kinnula V. (2001b). MnSOD expression is less frequent in tumour cells of invasive breast carcinomas than in in situ carcinomas or non-neoplastic breast epithelial cells. J. Pathol. 195,156-162.
46. Soini Y., Napankangas U., Jarvinen K., Kaarteenaho-Wiik R., Paakko P. and Kinnula V.L. (2001c). Expression of gamma-glutamyl cysteine synthetase in nonsmall cell lung carcinoma. Cancer 92, 2911-2919.
47. Soini Y., Kaarteenaho-Wiik R., Paakko P. and Kinnula V. (2003). Expression of antioxidant enzymes in bronchial metaplastic and dysplastic epithelium. Lung Cancer 39, 15-22.
48. Stover S.K., Gushansky G.A., Salmen J.J. and Gardiner C.S. (2000). Regulation of A-glutamate-cysteine ligase expression by oxidative stress in the mouse preimplantation embryo. Toxicol. Appl. Pharmacol. 168, 153-159.
49. Strehlow K., Rotter S., Wassmann S., Adam O., Grohe C., Laufs K., Bohm M. and Nickenig G. (2003.) Modulation of antioxidant enzyme expression and function by estrogen. Circ. Res. 93, 170-177.
50. Sun Q.A., Wu Y., Zappacosta F., Jeang K.T., Lee B.J., Hatfield D.L. and Gladyshev V.N. (1999). Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases. J. Biol. Chem. 274, 24522-24530.
51. Svensk A.M. Soini Y., Paakko P., Hirvikoski P. and Kinnula V.L. (2004). Differential expression of superoxide dismutases in lung cancer. Am. J. Clin. Pathol. 122, 395-404.
52. Tew K.D. (1994). Glutathione- associated enzymes in anticancer drug resistance. Cancer Res. 54, 4313-4320.
53. Tsutsui T., Koide H., Fukahori H., Isoda K., Higashiyama S., Maeda I., Tashiro F., Yamato E., Miyazaki J., Yodoi J., Kawase M. and Yagi K. (2003). Adenoviral transfection of hepatocytes with the thioredoxin gene confers protection against apoptosis and necrosis. Biochem. Biophys. Res. Commun. 307, 765-770.
54. Ueno M., Masutani H., Arai R.J., Yamauchi A., Hirot, K., Sakai T., Inamoto T., Yamaoka Y., Yodoi J. and Nikaido T. (1999). Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J. Biol. Chem. 274, 35809-35815.
55. Weisiger R. A. and Fridovich I. (1973). Mitochondrial superoxide simutase. Site of synthesis and intramitochondrial localization. J Biol. Chem. 248, 4793-4796.
56. Zelko I.N., Mariani T.J. and Folz R.J. (2002). Superoxide dismutase multigene family, a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic. Biol. Med. 33, 337-349.